More on CVALF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.56 |
|
|||
| Open | $1.54 | ||||
| 52 Wk High | $2.18 | ||||
| 52 Wk Low | $0.56 | ||||
| Day High | $1.54 | ||||
| Day Low | $1.54 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 800 | ||||
- Covalon appoints Dr. Murray Miller to board, grants DSUs
- Covalon Announces Appointment of New Director and DSU Grants
- Covalon Reports 2026 Second Quarter Results
- Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results
- Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
- Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
- Covalon Announces Grant of Deferred Share Units
- Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders
- Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026
- Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights
Entities mentioned with CVALF
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- HSBC | View Related Stories »
- Dividend | View Related Stories »
- Danaher/Beckman Coulter | View Related Stories »
- Donald J. Trump | View Related Stories »
- Show More...
